{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:34:26Z","timestamp":1781649266481,"version":"3.54.5"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7320-26","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T22:09:48Z","timestamp":1779487788000},"source":"Crossref","is-referenced-by-count":1,"title":["Heparin-induced Thrombocytopenia During Multiple Extracorporeal Mechanical Support for Fulminant Myocarditis: A Case Report with a Literature Review"],"prefix":"10.2169","author":[{"given":"Yukei","family":"Morita","sequence":"first","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Funahashi","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine, Japan"},{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Greinacher A. CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia. N Engl J Med 373: 252-261, 2015.","DOI":"10.1056\/NEJMcp1411910"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Helms J, Frere C, Thiele T, et al. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 21: 373-396, 2023.","DOI":"10.1016\/j.jtha.2022.11.014"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rewa OG, Villeneuve PM, Lachance P, et al. Quality indicators of continuous renal replacement therapy (CRRT) care in critically ill patients: a systematic review. Intensive Care Med 43: 750-763, 2017.","DOI":"10.1007\/s00134-016-4579-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Maruyama Y, Yoshida H, Uchino S, et al. Nafamostat mesilate as an anticoagulant during continuous veno-venous hemodialysis: a three-year retrospective cohort study. Int J Artif Organs 34: 571-576, 2011.","DOI":"10.5301\/IJAO.2011.8535"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (3 Suppl): 311s-337s, 2004.","DOI":"10.1378\/chest.126.3_suppl.311S"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 355: 809-817, 2006.","DOI":"10.1056\/NEJMcp052967"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Song D, Jin Y, Zhang Y, Zhou Z. Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis. Thromb J 22: 55, 2024.","DOI":"10.1186\/s12959-024-00624-5"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Lewis BE, Wallis DE, Berkowitz SD, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 103: 1838-1843, 2001.","DOI":"10.1161\/01.CIR.103.14.1838"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. P\u00e8ne F, Russell L, Aubron C. Thrombocytopenia in the intensive care unit: diagnosis and management. Ann Intensive Care 15: 25, 2025.","DOI":"10.1186\/s13613-025-01447-x"},{"key":"10","unstructured":"10. Anthon CT, P\u00e8ne F, Perner A, Azoulay E, et al. Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU). Intensive Care Med 49: 1327-1338, 2023."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Imaeda T, Oami T, Yokoyama T, et al. Epidemiology and outcomes of septic shock in Japan: a nationwide retrospective cohort study from a medical claims database by the Japan Sepsis Alliance (JaSA) study group. Crit Care 29: 309, 2025.","DOI":"10.1186\/s13054-025-05556-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Alqeeq BF, Ayyad M, Albandak M, et al. The clinical significance of thrombocytopenia in sepsis and septic shock: a systematic review and meta-analysis. BMC Anesthesiol 25: 327, 2025.","DOI":"10.1186\/s12871-025-03188-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Greinacher A, Selleng S. How I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood 128: 3032-3042, 2016.","DOI":"10.1182\/blood-2016-09-693655"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lubnow M, Berger J, Schneckenpointner R, et al. Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation. PLoS One 17: e0272577, 2022.","DOI":"10.1371\/journal.pone.0272577"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. L\u00fcsebrink E, Scherer C, Binzenh\u00f6fer L, et al. Heparin-Induced Thrombocytopenia in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation. J Clin Med 12: 2023.","DOI":"10.3390\/jcm12010362"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Frere C, Mazzeffi M, Maier CL, et al. Acquired von Willebrand syndrome during extracorporeal membrane oxygenation support: a comprehensive review of current evidence: communication from the ISTH SSC on perioperative and critical care thrombosis and hemostasis. J Thromb Haemost 22: 2608-2628, 2024.","DOI":"10.1016\/j.jtha.2024.06.007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Djavidi N, Boussouar S, Duceau B, et al. Vascular Complications After Venoarterial Extracorporeal Membrane Oxygenation Support: A CT Study. Crit Care Med 53: e96-e108, 2025.","DOI":"10.1097\/CCM.0000000000006476"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Taniguchi H, R\u00e4tsep I, Heinsar S, et al. Iliopsoas haematoma during extracorporeal membrane oxygenation: A registry report from the COVID-19 critical care consortium across 30 countries. Perfusion 39: 891-895, 2024.","DOI":"10.1177\/02676591231168285"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hart JP, Davies MG. Vascular Complications in Extracorporeal Membrane Oxygenation-A Narrative Review. J Clin Med 13: 2024.","DOI":"10.3390\/jcm13175170"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kameda S, Maeda A, Maeda S, et al. Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study. BMC Nephrol 25: 69, 2024.","DOI":"10.1186\/s12882-024-03506-0"},{"key":"21","unstructured":"21. Qasim Q. HEPARIN-INDUCED THROMBOCYTOPENIA SYNDROME AMONG HEMODIALYSIS PATIENTS AND DISEASE MANAGEMENT STRATEGY. Georgian Med News 344: 159-170, 2023."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tsai YF, Chen CA, Kuo C, Lin KC. Anti-PF4\/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients. Clin Exp Nephrol 16: 300-305, 2012.","DOI":"10.1007\/s10157-011-0555-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cerd\u00e1 J, Lameire N, Eggers P, et al. Epidemiology of acute kidney injury. Clin J Am Soc Nephrol 3: 881-886, 2008.","DOI":"10.2215\/CJN.04961107"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81: 442-448, 2012.","DOI":"10.1038\/ki.2011.379"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Mazzeffi M, Greenwood J, Tanaka K, et al. Bleeding, Transfusion, and Mortality on Extracorporeal Life Support: ECLS Working Group on Thrombosis and Hemostasis. Ann Thorac Surg 101: 682-689, 2016.","DOI":"10.1016\/j.athoracsur.2015.07.046"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sklar MC, Sy E, Lequier L, Fan E, Kanji HD. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review. Ann Am Thorac Soc 13: 2242-2250, 2016.","DOI":"10.1513\/AnnalsATS.201605-364SR"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7320-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T03:40:57Z","timestamp":1779507657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7320-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7320-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7320-26"}}